ICYMI, this week we had stories about adalimumab biosimilars, an expanded Banana Boat Hair & Scalp Sunscreen recall, what's trending in skin care for January 2023, and more.
Click here to answer this week's poll.
This review will explore various leukemia-related cutaneous findings and discuss the diagnosis and management of these conditions.
As Maui Derm Hawaii 2023, held at the Grand Wailea, comes to a close, one of the conference's co-founders explains its importance.
Preventing generalized pustular psoriasis may be possible based on recent data.
Christopher Bunick, MD, PhD, and Raj Chovatiya, MD, PhD, discuss the benefits of adalimumab-atto and the future of additional biosimilars in 2023.
Pemphigus is defined as a group of autoimmune, blistering disorders caused by circulating autoantibodies that bind to desmogleins, proteins that are vital to epidermal intercellular adhesion.
An additional batch of sunscreen has been added to the recall first announced on July 29, 2022 for the presence of benzene.
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of January.
Learn more about what in-depth topics were covered in the January 2023 issue of Dermatology Times®.
Granulomatous dermatitis includes a group of reactive dermatologic disorders characterized by distinct histopathological patterns, clinical manifestations, and associated diseases.
Explore a collection of the best skin tips for patients with skin of color.
In this week’s Pointers with Dr Portela, the 208SkinDoc discusses botox and other cosmetic treatments with Matthew Elias, DO, FAAD.
There are more than 355,000 nurse practitioners licensed in the United States in a variety of practice areas.
This week's edition of the Mainstream Patient features stories about sensitive skin around the eyes, health risks of sharing razors, keratin shampoos for stronger hair, and more.
It’s important to continuously look forward to our role in serving all patients and colleagues—especially those who are underrepresented.
Atopic dermatitis is not a "one-size-fits-all" condition.
This month's Legal Eagle column explores what information is required during an informed consent discussion.